Upgrade to SI Premium - Free Trial

Therapeuticsmd (TXMD) Reports In-Line Q1 Loss of 6c/Share

May 8, 2013 5:25 PM
Therapeuticsmd (NYSE: TXMD) reported Q1 EPS of ($0.06), in-line ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings